Quick Answer
Vaxart, Inc. reported Net Income of $16.33 million for fiscal year 2025.
Vaxart, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $16.33M | +124.4% |
| 2024 | -$66.95M | +18.8% |
| 2023 | -$82.47M | +23.5% |
| 2022 | -$107.76M | -52.9% |
| 2021 | -$70.47M | -118.7% |
| 2020 | -$32.22M | -72.8% |
| 2019 | -$18.64M | -3.5% |
| 2018 | -$18.01M | -87.9% |
| 2017 | -$9.58M | +67.4% |
| 2017 | -$29.40M | -15.7% |
| 2016 | -$25.40M | -33.0% |
| 2015 | -$19.10M | -73.6% |
| 2014 | -$11.00M | -23.6% |
| 2013 | -$8.90M | +53.6% |
| 2012 | -$19.20M | -323.7% |
| 2011 | -$4.53M | +82.2% |
| 2011 | -$25.40M | -2992.9% |
| 2010 | $878.0K | +104.7% |
| 2009 | -$18.73M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.14M | +42.2% | +45.7% |
| June 30, 2025 | -$14.99M | +9.0% | +3.9% |
| March 31, 2025 | -$15.59M | +36.1% | -10.7% |
| September 30, 2024 | -$14.08M | +19.1% | +14.5% |
| June 30, 2024 | -$16.47M | +27.0% | +32.6% |
| March 31, 2024 | -$24.42M | +2.9% | -40.3% |
| September 30, 2023 | -$17.40M | +40.6% | +22.8% |
| June 30, 2023 | -$22.55M | +23.4% | +10.3% |
- Vaxart, Inc. showed an increase of +124.4% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, Vaxart, Inc.’s net income has grown by 187.2% (from -$18.73 million to $16.33 million).
- The most recent figure is from Vaxart, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: